POTENTIALS FOR THE USE OF URSODEOXYCHOLIC ACID IN THE THERAPY OF INTRAHEPATIC CHOLESTASIS OF PREGNANCY


Yu.S. Gulenchenko (1), E.V. Partsvania-Vinogradova (2, 3), D.T. Dicheva (3), D.N. Andreev (3)

(1) FBHCI SCH MIA of Russia, Moscow; (2) Branch Branch SBHCI CP № 115 MHCD CP № 79, Moscow; (3) SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH, Moscow
According to modern concepts, intrahepatic cholestasis of pregnancy (IHCP) is a cholestatic liver disease that develops in II and III trimesters of pregnancy, and characterized by itching and increased concentration of bile acids in the blood serum. Currently, ursodeoxycholic acid is considered as the drug of choice for the treatment of IHCP as defined by substantial evidence of efficacy and safety of the drug within the treatment of this pathology.

About the Autors


E.V. Partsvania-Vinogradova – therapists at the Branch SBHCI CP № 115 MHCD CP № 79, resident physician at the Department of Propedeutics of Internal Diseases and Gastroenterology SBEI HPE MSMSU n.a. A.I. Evdokimov of RMPH, Moscow; e-mail: katrin3108@mail.ru


Similar Articles


Бионика Медиа